乔爱敏,王宜海,程鹏
QIAO Ai-min,WANG Yi-hai,CHENG Peng

• 1:广东药科大学生命科学与生物制药学院生物资源和创新药物研究中心
• 2:广东药科大学药学院广东省先导化合物与药物发现工程中心

摘要(Abstract)：

目的综述AM80他米巴罗汀(tamibarotene,AM80)抗阿尔治海默症(Alzheimer's Disease,AD)药理作用及其作用机制、不良反应以及临床用药安全等最新研究进展。方法通过阅读近几年国内外的相关文献,对AM80抗阿尔治海默症最新研究报道进行详细的归纳总结。结果 AM80是一个合成的维甲酸受体激动剂,具有很好的抗阿尔治海默症作用。AM80作为一个多靶点药物,它通过转录调控多种与AD发病相关的基因;能够减少β淀粉样肽在脑部的沉积;还能够改善AD小鼠的学习记忆功能;有效弥补脑内乙酰胆碱的减少;并且能够增加小胶质细胞对Aβ(beta amyloid)的降解功能并伴随脑部炎症的减少。结论 AM80有望成为一个安全和有效的预防和治疗AD的药物,具有广泛的临床应用前景。
Objective To summarize progress in the latest research of pharmacological effects,adverse effects and clinical safety of Tamibarotene(AM80) in the treatment of Alzheimer' s disease(AD). Methods The latest researches about AM80 in Alzheimer's disease are summarized by reviewing the relevant literatures in the recent years at home and abroad. Results Tamibarotene(AM80),a synthetic retinoid approved in Japan for treatment of acute promyelocytic leukemia(APL), is a retinoic acid receptor(RAR) agonist and it is considered to be a promising candidate drug for treatment of AD because of its transcriptional controls of multiple target genes involved in etiology and pathology of AD. AM80 could reduce the A β deposit in the brain; improve the learning and memory function of AD mice; ameliorate the decrease of cortical acetylcholineand reduce secretion of proinflammatory cytokines as well as enhance the microgia cell degradating A β function. Conclusions AM80 is expected to be a safe and effective candidate for the prevention and treatment of Alzheimer's disease,with a wide range of clinical application prospects.

关键词(KeyWords)： 他米巴罗汀;阿尔治海默症;维甲酸受体
AM80;Alzheimer's disease;retinoic acid receptor

Abstract:

Keywords:

基金项目(Foundation): 广东省自然科学基金(No.2016A030313732);; 广东省医学科学基金(No.A2015248)

作者(Author): 乔爱敏,王宜海,程鹏
QIAO Ai-min,WANG Yi-hai,CHENG Peng

DOI: 10.14066/j.cnki.cn21-1349/r.2017.011.012

参考文献(References)：

• [1]DING Y,QIAO A M,WANG Z Q,et al.Retinoic acid attenuatesβ-amyloid deposition and rescues memory deficits in Alzheimer's disease transgenic mice[J].J Neurosci,2008,28(45):11622-11634.
• [2]LANE M A,BAILEYS J.Role of retinoid signalling in the adult brain[J].Prog Neurobiol,2005,75(4):275-293.
• [3]RUPINDER K,SODH I,NIRMAL S.Retinoids as potential targets for Alzheimer's disease[J].Pharmacol Biochem Be,2014,120:117-123.
• [4]LEE H P,GEMMA C,ZHU X W,et al.All-trans-retinoic acid as a novel therapeutic strategy for Alzheimer's disease[J].Expert Rev Neurother,2009,9(11):1615-1621.
• [5]WANG R,CHEN S,LIU Y,et al.All-trans-retinoic acid reduces BACE1 expression under inflammatory conditions via modulation of nuclear factorκB(NFκB)signaling[J].J Biol Chem,2015,290(37):22532-22542.
• [6]SODHI R K,SINGH N.All-trans retinoic acid rescues memory deficits and neuropathological changes in mouse model of streptozotocin-induced dementia of Alzheimer's type[J].Prog Neuropsychopharmacol Biol Psychiatry,2013,40:38-46.
• [7]ANNA K,JESSICA A,SABINE K,et al.Regulation of secretases by all-trans-retinoic acid[J].FEBS,2009,276:2645-2655.
• [8]HIROKI U,HIROSHI F,MASAYUKI E,et al.Regulation of retinoidal actions by diazepinylbenzoic acids.retinoid synergists which activate the RXR-RAR heterodimers[J].J Med Chem,1997,40(26):4222-4234.
• [9]KALRA J,KHAN A.Reducing Aβload and tau phosphorylation:Emerging perspective for treating Alzheimer's disease[J].Eur J Pharmacol,2015,21,764:571-581.
• [10]迟天燕,王力华,纪雪飞,等.文冠甲壳苷对侧脑室注射致痴呆模型小鼠学习记忆障碍的改变作用[J].沈阳药科大学学报,2010,27(4):314-319.
• [11]WEST S,BHUGRA P.Emerging drug targets for Aβand tau in Alzheimer's disease:a systematic review[J].Br J Clin Pharmacol,2015,80(2):221-234.
• [12]HENEKA M T,CARSON M J,El KHOURY J,et al.Neuroinflammation in Alzheimer's disease[J].Lancet Neurol,2015,14(4):388-405.
• [13]KAWAHARA K,NISHI K,SUENOBU M,et al.Oral administration of synthetic retinoid Am80(Tamibarotene)decreases brainβ-amyloid peptides in APP23mice[J].Biol Pharm Bull,2009,32(7):1307-1309.
• [14]MIWAKO I,SHUDO K.Oral administration of synthetic retinoid Am80 inhibits the development of type 1 diabetes in non-obese diabetic(NOD)mice[J].Biol Pharm Bull,2009,32(1):157-159.
• [15]KOHICHI K,MICHITA S,HIDEYUKI O,et al.Cooperative therapeutic action of retinoic acid receptor and retinoid X Receptor agonists in a mouse model of Alzheimer's Disease[J].J Alzheimer's Dis,2014,42:587-605.
• [16]ENDRES K,FAHRENHOLZ F.Regulation of alphasecretase ADAM10 expression and activity[J].Exp Brain Res,2012,217:343-352.
• [17]STEFAN F.LICHTENTHALE R.Alpha-secretase in Alzheimer's disease:molecular identity,regulation and therapeutic potential[J].J Neurochem,2011,116:10-21.
• [18]KITAOKA K,SHIMIZU N,ONO K,et al.The retinoic acid receptor agonist Am80 increases hippocampal ADAM10 in aged SAMP8 mice[J].Neuropharmacol,2013,72:58-65.
• [19]HEPPNER F L,RANSOHOFF R M,BECHER B.Immune attack:the role of inflammation in Alzheimer disease[J].Nat Rev Neurosci,2015,16(6):358-372.
• [20]候文婧,李寒雪.阿尔治海默症与炎症因子[J].世界最新医学信息文摘,2013,13(6):62-63.
• [21]MATSUSHITA H,HIJIOKA M,ISHIBASHI H,et al.Suppression of CXCL2 upregulation underlies the therapeutic effect of the retinoid Am80 on intracerebral hemorrhage in mice[J].J Neurosci Res,2014,92(8):1024-1034.
• [22]KATSUKI H,KURIMOTO E,TAKEMORI S,et al.Retinoic acid receptor stimulation protects midbrain dopaminergic neurons from inflammatory degeneration via BDNF-mediated signaling[J].J Neurochem,2009,110(2):707-718.
• [23]WANG T,SATORU N,KEIKO B,et al.The effect of Am-80,one of retinoids derivatives on experimental allergic encephalomyelitis in rats[J].Life Sci,2000,67(15):1869-1879.
• [24]KEINO H,WATANABE T,SATO Y,et al.Oral administration of retinoic acid receptor-alpha/beta-specific ligand Am80 suppresses experimental autoimmune uveoretinitis[J].Invest Ophthalmol Vis Sci,2011,52(3):1548-1556.
• [25]GRAMMAS P,LI Y,SANCHEZ A,et al.Targeting vascular activation:A novel therapeutic strategy for Alzheimer's disease[J].J Nutr Health Aging,2011,15:S11-S12.
• [26]MEY J.New therapeutic target for CNS injury?The role of retinoic acid signaling after nerve lesions[J].J Neurobiol,2006,66:757-779.
• [27]SHIOHIRA H,KITAOKA A,SHIRASAWA H,et al.AM80 induces neuronal differentiation in a human neuroblastoma NH-12 cell line[J].Int J Mol Med,2010,26:393-399.
• [28]TAKENAGA M,OHTA Y,TOKURA Y,et al.The effect of Am-80,a synthetic retinoid,on spinal cord injury-induced motor dysfunction in rats[J].Biol Pharm Bull,2009,32:225-231.
• [29]肖志龙,徐丽君.脑脑淀粉样血管病神经影像相关标志物研究进展[J].中国神经精神疾病杂志.2015,41(6):377-379.
• [30]BELL R D,ZLOKOVIC B V.Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease[J].Acta Neuropathol,2009,118:103-113.
• [31]NAGAI R,SUZUKI T,AIZAWA K,et al.Significance of the transcription factor KLF5 in cardiovascular remodeling[J].J Thromb Haemost,2005,3:1569-1576.
• [32]FIJIU K,MANABE I,ISHIHARA A,et al.Synthetic retinoid Am80 suppresses smooth muscle phenotypic modulation and in-stent neointima formation by inhibiting KLF5[J].Circ Res,2005,97:1132-1141.
• [33]MARIA B,GONCALVES,EARL C,et al.Amyloidβinhibits retinoic acid synthesis exacerbating Alzheimer disease pathology which can be attenuated by an retinoic acid receptorαagonist[J].Eur J Neurosci,2013,37:1182-1192.
• [34]影近弘之.维甲酸-癌症预防与治疗药物[J].日本医学介绍,2006,27(1):32-34.